Lin Yee Chen, MD wins new NHLBI Grant
Lin Yee Chen, MD, MS has just been awarded a new R01 grant from the National Heart, Lung, and Blood Institute, "Left Atrial Abnormality and Atrial Fibrillation-Related Cerebral Infarcts and Cognitive Decline" (R01HL141288, 2018-2022). It is complementary to his current R01-funded project, “Significance of Atrial Fibrillation and Atrial Fibrillation Burden Detected by Novel ECG Monitoring in Community-Dwelling Elderly.” The overarching goal of this new project is to clarify whether it is AF per se, or the underlying left atrial abnormality, that is the principal driver of outcomes that are currently attributable to AF.
Thanks to Chen’s continuing research, the University of Minnesota is well-positioned to impact the field of atrial fibrillation and answer many questions such as the prognostic significance of atrial fibrillation burden and subclinical atrial fibrillation, and the mechanisms underlying atrial fibrillation-related stroke and dementia.
Lin Yee Chen, MD, MS awarded grant from NHLBI
Cardiologist Lin Yee Chen, MD, MSrecently was awarded an R01 grant, "Significance of Atrial Fibrillation and Atrial Fibrillation Burden Detected by Novel ECG Monitoring in Community-Dwelling Elderly" from the National Heart, Lung, and Blood Institute. This is a $3.74 million grant over 5 years (2016–2021).
Dr. Chen’s study is a multi-center project that involves 2-week ambulatory heart rhythm monitoring in 4,000 participants to:
- Define the role of screening for subclinical atrial fibrillation in the elderly
- Clarify the relationship of atherosclerotic risk factors in mid-life to atrial fibrillation burden in older age, and
- Define the prognostic significance of atrial fibrillation burden. This project is an ancillary study to the Atherosclerosis Risk in Communities (ARIC) Study.
Findings from Dr. Chen’s research will impact the field and clinical practice of atrial fibrillation.